Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Malignant Lymphoma

  Free Subscription


Articles published in Cancer Lett

Retrieve available abstracts of 16 articles:
HTML format



Single Articles


    March 2021
  1. YOU H, Wei L, Kaminska B
    Emerging insights into origin and pathobiology of primary central nervous system lymphoma.
    Cancer Lett. 2021 Mar 22. pii: S0304-3835(21)00104.
    PubMed     Abstract available


    January 2021
  2. MA Y, Bauer V, Riedel T, Ahmetlic F, et al
    Interleukin-10 counteracts T-helper type 1 responses in B-cell lymphoma and is a target for tumor immunotherapy.
    Cancer Lett. 2021;503:110-116.
    PubMed     Abstract available


    December 2020
  3. CASAGRANDE N, Borghese C, Favero A, Vicenzetto C, et al
    Trabectedin overcomes doxorubicin-resistance, counteracts tumor-immunosuppressive reprogramming of monocytes and decreases xenograft growth in Hodgkin lymphoma.
    Cancer Lett. 2020 Dec 13. pii: S0304-3835(20)30665.
    PubMed     Abstract available


  4. CHEN XR, Yuan HH, Guo JH, Zhang WY, et al
    A signal peptide derived from Hsp60 induces protective cytotoxic T lymphocyte immunity against lymphoid malignancies independently of TAP and classical MHC-I.
    Cancer Lett. 2020;494:47-57.
    PubMed     Abstract available


    October 2020
  5. LU F, Zhao Y, Pang Y, Ji M, et al
    NLRP3 inflammasome upregulates PD-L1 expression and contributes to immune suppression in lymphoma.
    Cancer Lett. 2020 Oct 19. pii: S0304-3835(20)30547.
    PubMed     Abstract available


    August 2020
  6. LI X, Wei Y, Wei X
    Napabucasin, a novel inhibitor of STAT3, inhibits growth and synergises with doxorubicin in diffuse large B-cell lymphoma.
    Cancer Lett. 2020 Aug 13. pii: S0304-3835(20)30385.
    PubMed     Abstract available


    January 2020
  7. CHEN R, Wang M, Liu Q, Wu J, et al
    Sequential treatment with aT19cells generates memory CAR-T cells and prolongs the lifespan of Raji-B-NDG mice.
    Cancer Lett. 2020;469:162-172.
    PubMed     Abstract available


    April 2019
  8. HIGUCHI T, Matsuo K, Hashida Y, Kitahata K, et al
    Epstein-Barr virus-positive pyothorax-associated lymphoma expresses CCL17 and CCL22 chemokines that attract CCR4-expressing regulatory T cells.
    Cancer Lett. 2019 Apr 3. pii: S0304-3835(19)30217.
    PubMed     Abstract available


  9. LABI V, Schoeler K, Melamed D
    miR-17 approximately 92 in lymphocyte development and lymphomagenesis.
    Cancer Lett. 2019;446:73-80.
    PubMed     Abstract available


    February 2019
  10. WANG R, Li L, Duan A, Li Y, et al
    Crizotinib enhances anti-CD30-LDM induced antitumor efficacy in NPM-ALK positive anaplastic large cell lymphoma.
    Cancer Lett. 2019 Feb 8. pii: S0304-3835(19)30065.
    PubMed     Abstract available


    December 2018
  11. PORCELLI L, Stolfa D, Stefanachi A, Di Fonte R, et al
    Synthesis and biological evaluation OF N-biphenyl-nicotinic based Moiety compounds: A new class of antimitotic agents for the treatment of Hodgkin lymphoma.
    Cancer Lett. 2018 Dec 21. pii: S0304-3835(18)30728.
    PubMed     Abstract available


    August 2018
  12. QU C, Kunkalla K, Vaghefi A, Frederiksen JK, et al
    Smoothened Stabilizes and Protects TRAF6 from Degradation: A Novel Non-Canonical Role of Smoothened with Implications in Lymphoma Biology.
    Cancer Lett. 2018 Aug 27. pii: S0304-3835(18)30538.
    PubMed     Abstract available


    February 2018
  13. ESPINOZA JL, Matsumoto A, Tanaka H, Matsumura I, et al
    Gastric microbiota: An emerging player in Helicobacter pylori-induced gastric malignancies.
    Cancer Lett. 2018;414:147-152.
    PubMed     Abstract available


    July 2017
  14. SOLE C, Larrea E, de Pinto G, Tellaexte M, et al
    miRNAs in B-cell lymphoma: Molecular mechanisms and biomarker potential.
    Cancer Lett. 2017 Jul 27. pii: S0304-3835(17)30456.
    PubMed     Abstract available


  15. BHATTI IA, Abhari BA, Fulda S
    Identification of a synergistic combination of Smac mimetic and Bortezomib to trigger cell death in B-cell non-Hodgkin lymphoma cells.
    Cancer Lett. 2017 Jul 14. pii: S0304-3835(17)30434.
    PubMed     Abstract available


    March 2017
  16. GALLO A, Vella S, Miele M, Timoneri F, et al
    Global profiling of viral and cellular non-coding RNAs in Epstein-Barr virus-induced lymphoblastoid cell lines and released exosome cargos.
    Cancer Lett. 2017;388:334-343.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Lymphoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: